Abiopharma

Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps

Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results

Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy

Apellis Announces 5-Year GALE Data Showing SYFOVRE® (pegcetacoplan injection) Delayed Progression of Geographic Atrophy by ~1.5 Years

BD Expands PureWick™ Portfolio with First-of-its-Kind Portable Solution to Confidently Manage Urinary Incontinence On the Go

Pharvaris Reports Third Quarter 2025 Financial Results and Provides Business Update

New SEC Form for ResMed Inc.

ICON plc to Present at the Jefferies London Healthcare Conference

Clearmind Medicine Announces Notice of Patent Publication for Depression Treatment

Rockwell Medical Announces Third Quarter 2025 Results